NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN ·

NeuroSense Therapeutics Ltd. (NRSN) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for NeuroSense Therapeutics Ltd. in 2026. The next earnings report is expected on September 2, 2026.

Earnings calendar

Next earnings date

02 Sep 2026

In 12 days

EPS estimate

-0.20

Revenue estimate

0

Past earnings

22 Jun 2026
EPS actual
—
estimate -0.08
Revenue actual
—
estimate 514.1K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
31 Mar 2026
EPS actual
-0.24 (-231.9%)
estimate -0.07
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
26 Nov 2025
EPS actual
-0.04 (+8.5%)
estimate -0.04
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Sector
Healthcare
Industry
Biotechnology
Country
Israel
Exchange
Nasdaq
CEO
Alon Ben-Noon
Employees
17
IPO date
09 Dec 2021
ISIN
IL0011809592
Website
neurosense-tx.com

Frequently asked questions

When does NeuroSense Therapeutics Ltd. (NRSN) next report earnings?

NeuroSense Therapeutics Ltd. (NRSN) is scheduled to report earnings on September 2, 2026.

What was NeuroSense Therapeutics Ltd.'s most recent earnings date?

NeuroSense Therapeutics Ltd. (NRSN) last reported earnings on June 22, 2026.

Where is NeuroSense Therapeutics Ltd. stock listed?

NeuroSense Therapeutics Ltd. (NRSN) is listed on Nasdaq.